← NSFG Explorer

NSFG Individual Reports

All deep-dive analysis pages built from the 2022–2023 NSFG Female Respondent data. EA reports cover method discontinuation (survey section EA); METHX reports use the 48-month contraceptive calendar.

Method Discontinuation EA section · who stopped, and why
EA-1
Birth Control Pills REPORT
Discontinuation rate, reasons for stopping, and racial/ethnic breakdown. 28.9% of pill users stopped during the reference period.
→ EA-2
Condoms REPORT
Discontinuation patterns for male condom use. 7.6% of users stopped during the reference period.
→ EA-3
Partner's Vasectomy REPORT
Reliance on partner vasectomy as contraception. 0.2% discontinuation rate reflects the permanent nature of the method.
→ EA-4
Depo-Provera (Injectable) REPORT
Discontinuation rate and reasons for the injectable contraceptive. 34.2% of users stopped — the highest rate among hormonal methods.
→ EA-6
Withdrawal REPORT
Discontinuation patterns for the withdrawal method. 5.1% of users stopped during the reference period.
→ EA-9
Contraceptive Patch REPORT
Patch discontinuation rate and reasons. 32.6% of users stopped — among the higher rates for hormonal methods.
→ EA-10
Vaginal Ring (NuvaRing) REPORT
Ring discontinuation patterns and user demographics. 34.0% of users stopped during the reference period.
→ EA-11
Emergency Contraception REPORT
Usage patterns for emergency contraception (morning-after pill). Distinct from regular contraceptive methods — not a discontinuation analysis.
→ EA-13c
Hormonal Implant REPORT
Implant discontinuation rate and reasons for removal. 29.1% of users stopped — notable given the 3-year effective duration.
→ EA-13d
IUD (Intrauterine Device) REPORT
IUD discontinuation rate and reasons. 23.4% of users stopped — lowest among LARCs despite long effective duration.
→ EA-16/17
Method Dissatisfaction — Cross-Method Comparison REPORT
Side-by-side comparison of dissatisfaction rates across all contraceptive methods. Includes METHDISS and METHSTOP01–09 variables.
→
Longitudinal Calendar Analyses METHX section · 48-month retrospective
METHX
Contraceptive Method Usage — 4-Year Retrospective REPORT
All methods tracked across the 4 years before interview. Three-way denominator toggle: method users / all respondents / non-EC drug market. Pill declining 31% → 26%; IUD rising.
→ METHX
Pill, IUD, Implant, Ring & Depo by Age Group REPORT
Age-stratified use of five methods across seven age groups (15–50) and four years. Dumbbell charts show yr−3 → interview year shift per cohort.
→